Brian L Fish Selected Research

Fosinopril (Monopril)

11/2014	Model development and use of ACE inhibitors for preclinical mitigation of radiation-induced injury to multiple organs.
9/2014	Mitigation of experimental radiation nephropathy by renin-equivalent doses of angiotensin converting enzyme inhibitors.
1/2012	Angiotensin converting enzyme inhibitors mitigate collagen synthesis induced by a single dose of radiation to the whole thorax.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian L Fish Research Topics

Disease

14	Radiation Injuries (Radiation Sickness) 01/2022 - 03/2009
9	Pneumonia (Pneumonitis) 01/2022 - 01/2007
9	Wounds and Injuries (Trauma) 01/2021 - 12/2009
8	Radiation Pneumonitis 01/2022 - 07/2012
6	Fibrosis (Cirrhosis) 06/2015 - 03/2004
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2014 - 01/2007
3	Neoplasms (Cancer) 01/2022 - 01/2019
3	Lung Injury 01/2022 - 04/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2019
2	Cardiotoxicity 01/2022 - 01/2019
2	Brain Injuries (Brain Injury) 01/2021 - 01/2021
2	Dermatitis 09/2014 - 04/2013
2	Vascular System Injuries 11/2012 - 11/2012
2	Tachypnea 07/2012 - 12/2009
2	Renal Insufficiency (Renal Failure) 01/2011 - 03/2009
1	Lung Neoplasms (Lung Cancer) 10/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Pulmonary Hypertension 01/2019
1	Ventricular Remodeling 01/2019
1	Acute Radiation Syndrome 11/2016
1	Colitis 10/2016
1	Azotemia 03/2016
1	Myocardial Infarction 06/2015
1	Myocardial Ischemia (Ischemic Heart Diseases) 06/2015
1	Heart Diseases (Heart Disease) 06/2015
1	Body Weight (Weight, Body) 06/2015
1	Pleural Effusion (Pleural Effusions) 03/2015
1	Heart Failure 03/2015
1	Heart Injuries 09/2013
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 01/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2007

Drug/Important Bio-Agent (IBA)

8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 01/2007
6	Lisinopril (Prinivil)FDA LinkGeneric 01/2022 - 11/2016
6	Captopril (Capoten)FDA LinkGeneric 09/2014 - 12/2009
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022 - 01/2007
4	Enalapril FDA LinkGeneric 03/2016 - 01/2012
4	CollagenIBA 06/2015 - 12/2009
3	Fosinopril (Monopril)FDA LinkGeneric 11/2014 - 01/2012
2	SaltsIBA 01/2022 - 01/2019
2	Urea (Carbamide)FDA LinkGeneric 05/2020 - 03/2009
2	NitrogenIBA 05/2020 - 03/2009
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2016
2	AntioxidantsIBA 01/2019 - 08/2009
2	Proteins (Proteins, Gene)FDA Link 03/2015 - 01/2007
2	EUK 207IBA 04/2013 - 11/2012
2	CatalaseIBA 04/2013 - 11/2012
2	Superoxide DismutaseIBA 04/2013 - 11/2012
2	Drinking WaterIBA 07/2012 - 03/2009
2	SeleniumIBA 09/2011 - 03/2009
2	Losartan (Cozaar)FDA LinkGeneric 01/2011 - 12/2009
2	Angiotensin IIIBA 08/2007 - 01/2007
1	ReninIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	AldosteroneIBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Nerve Growth Factor (NGF)IBA 01/2021
1	6,7-dihydroxyflavoneIBA 01/2021
1	SirtuinsIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2016
1	Alkaline PhosphataseIBA 10/2016
1	LDL CholesterolIBA 06/2015
1	Triglycerides (Triacylglycerol)IBA 06/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2015
1	Simvastatin (Zocor)FDA LinkGeneric 06/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2015
1	LipidsIBA 09/2013
1	CholesterolIBA 04/2013
1	CytokinesIBA 04/2010
1	Angiotensin Receptor AntagonistsIBA 01/2007
1	ActomyosinIBA 01/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2007
1	Type 2 Angiotensin ReceptorIBA 03/2004

Therapy/Procedure

6	Radiotherapy 10/2022 - 01/2019
3	Therapeutics 04/2020 - 03/2015
2	Polypharmacy 01/2021 - 01/2021
1	Immunotherapy 04/2020
1	Treatment Delay 11/2012
1	Subcutaneous Injections 11/2012